Successful serial medical device and diagnostics entrepreneur. I started my career learning in established, mature companies. Thereafter, I led five medical device and diagnostics companies, being one of the first ten employees in all. Happily, four of the five have been successful, thriving entities, and are significant divisions in large medical device and diagnostics companies today, generating over $6B in annual revenues. Skills include market/ technology "fit" assessment, management team building, patent portfolio assessment (have managed large portfolios, and am a named inventor on 46 US patents to date, an additional 20 published, numerous OUS filings), designing and implementing clinical trials (was on advisory board of the largest NIH Randomized trial to date, the Diabetes Control and Complications Trial, have established US and EU feasibility and approval trials at all five companies), thorough understanding of FDA and EU approval process as all five companies went through them, gaining approval (including one successful appeal in the US), corporate Mergers and Acquisition and Initial Public Offering. Experience in the following medical disciplines: Outpatient Diabetes, Interventional Cardiology, Interventional Radiology (including Neuro), Intensive Care Unit, Cardiac Surgery, and Pulmonology. Fund Raising experience: have raised venture monies for each of the five companies I have led, totaling more than $400M. Four of the five companies have been purchased, and are today stand alone divisions in large medical device and diagnostics companies. Exits to date: more than $5B. Specific accomplishments: MiniMed: achieved cash flow positive status and an Initial Public Offering. PercuSurge: Phase I, II, and III trials, resulting in acquisition offer prior to US approval. Winner of prestigious Phoenix award for year 2001 Emerging Growth company. TheraSense: Redirected company's technical efforts towards minimally invasive SMBG, raised Series A. Ekos: Turned around failed venture, re-directed technology to become first Pulmonary Embolism therapy.OptiScan: Achieved US FDA approval (only one of 21 that attempted to create an automated ICU CGM that was approved).At this point in my career, I am happy to help the next generation of entrepreneurs achieve their dream.